Disclosures for "Effectiveness and Safety of ABAStroke in Cognitive Rehabilitation for Post-stroke Patients: A Randomized Controlled Study"
-
Dr. Wrona has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Wrona has received research support from ABAStroke Company.
-
Dr. Piechowski-Jozwiak has nothing to disclose.
-
Mr. Homa has received research support from ABAStroke Company.
-
Dr. Wlodarczyk has nothing to disclose.
-
Miss Sarba has received research support from ABAStroke Company.
-
Dr. Slowik has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer, . Dr. Slowik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Slowik has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.